Chordate Medical Holding Stock Fundamentals
| CMH Stock | 18.05 0.80 4.24% |
Chordate Medical Holding fundamentals help investors to digest information that contributes to Chordate Medical's financial success or failures. It also enables traders to predict the movement of Chordate Stock. The fundamental analysis module provides a way to measure Chordate Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chordate Medical stock.
Chordate |
Chordate Medical Holding Company Current Valuation Analysis
Chordate Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Chordate Medical Current Valuation | 102.78 M |
Most of Chordate Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chordate Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Chordate Medical Holding has a Current Valuation of 102.78 M. This is 99.28% lower than that of the Healthcare sector and 99.17% lower than that of the Medical Devices industry. The current valuation for all Sweden stocks is 99.38% higher than that of the company.
Chordate Medical Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chordate Medical's current stock value. Our valuation model uses many indicators to compare Chordate Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chordate Medical competition to find correlations between indicators driving Chordate Medical's intrinsic value. More Info.Chordate Medical Holding is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chordate Medical's earnings, one of the primary drivers of an investment's value.Chordate Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chordate Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chordate Medical could also be used in its relative valuation, which is a method of valuing Chordate Medical by comparing valuation metrics of similar companies.Chordate Medical is currently under evaluation in current valuation category among its peers.
Chordate Fundamentals
| Return On Equity | -1.68 | |||
| Return On Asset | -0.71 | |||
| Operating Margin | (54.40) % | |||
| Current Valuation | 102.78 M | |||
| Shares Outstanding | 157.71 M | |||
| Shares Owned By Insiders | 39.97 % | |||
| Price To Book | 5.80 X | |||
| Price To Sales | 3,320 X | |||
| Revenue | 618.01 K | |||
| Gross Profit | 1.93 M | |||
| EBITDA | (16.85 M) | |||
| Net Income | (19.76 M) | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (17.43 M) | |||
| Earnings Per Share | (0.18) X | |||
| Beta | 1.27 | |||
| Market Capitalization | 80.99 M | |||
| Total Asset | 31.22 M | |||
| Net Asset | 31.22 M |
About Chordate Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chordate Medical Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chordate Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chordate Medical Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.